Ireland - English - HPRA (Health Products Regulatory Authority)

rosemont pharmaceuticals ltd - levetiracetam - oral solution - 100 mg/ml

Malta - English - Medicines Authority

fair-med healthcare gmbh planckstr. 13, 22765 hamburg, germany - levetiracetam - oral solution - levetiracetam 100 mg/ml - antiepileptics

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - levetiracetam - oral solution - 100mg/1ml

Malta - English - Medicines Authority

accord healthcare limited - levetiracetam - oral solution - levetiracetam 100 mg/ml - antiepileptics

Malta - English - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - levetiracetam - oral solution - levetiracetam 100 mg/ml - antiepileptics

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord healthcare ltd - levetiracetam - oral solution - 100mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

viiv healthcare pty ltd - lamivudine, quantity: 10 mg/ml - oral liquid, solution - excipient ingredients: citric acid; sodium hydroxide; propyl hydroxybenzoate; purified water; hydrochloric acid; sodium citrate dihydrate; methyl hydroxybenzoate; propylene glycol; sucrose; flavour - 3tc (lamivudine) in combination with other antiretroviral agents is indicated for the treatment of hiv infected adults and children.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - magnesium hydroxide, quantity: 24 mg/ml; aluminium hydroxide, quantity: 50 mg/ml; magnesium trisilicate, quantity: 24 mg/ml - oral liquid, suspension - excipient ingredients: hymetellose; sodium hydroxide; propyl hydroxybenzoate; glycerol; purified water; hydrogen peroxide; saccharin sodium; peppermint oil; ethanol; vanillin; ethyl hydroxybenzoate; sodium hypochlorite - fast, effective and long lasting relief from: indigestion, heartburn, upset stomach.

United States - English - NLM (National Library of Medicine)

mckesson corporation dba sky packaging - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam oral solution  is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy. levetiracetam oral solution  is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy. levetiracetam oral solution  is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy. levetiracetam is contraindicated in patients with a hypersensitivity to levetiracetam. reactions have included anaphylaxis and angioedema [see warnings and precautions (5.4)] . levetiracetam blood levels may decrease during pregnancy [see warnings and precautions (5.10)] . teratogenic effects pregnancy category c   there are no adequate and controlled studies in pregnant women. in animal studies, levetiracetam produced evidence of dev

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - levetiracetam - oral solution - levetiracetam 100 mg/ml - antiepileptics